AZN and AMGN Related Headlines
Go Back- Roche obesity drug shows 15.5% weight loss in diabetes trial
- AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring
- Trump to announce prescription drug price agreements
- White House: Trump on Friday to announce more 'deals that will lower prices of drugs and pharmaceuticals'
- Bernstein on IRA pricing: $245 really is the floor
- Tezspire wins EU approval for chronic rhinosinusitis with nasal polyps
